Health
Investigational Alzheimer’s drug reduces molecular markers of the disease – News-Medical.Net
An investigational Alzheimer’s drug reduced molecular markers of disease and curbed neurodegeneration in the brain, without demonstrating…
An investigational Alzheimer’s drug reduced molecular markers of disease and curbed neurodegeneration in the brain, without demonstrating evidence of cognitive benefit, in a phase 2/3 clinical trial led by researchers at Washington University School of…
Continue Reading
-
Noosa News21 hours agoEnsure voices are heard – Proctor
-
Noosa News17 hours agoMajor crash on Gateway Motorway snarls morning commute
-
Noosa News22 hours agoEric Bana Is Back in Murder-Mystery Mode (and in Scenic Surroundings) in the Trailer for New Netflix Series ‘Untamed’
-
Business19 hours agoUp 34% this year, can Challenger shares keep rising according to Macquarie?